Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema

Clinical trial NCT00989989 · COMPLETED

Trial details

NCT number: NCT00989989
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2009-09-01
Primary completion: 2011-08-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.